Company

Everest Medicines Ltd

Headquarters: Shanghai, China

Employees: 227

CEO: Dr. Kerry Levan Blanchard M.D., Ph.D.

HKEX: 1952 +7.31%

Market Cap

HK$6.06 Billion

HKD as of Jan. 1, 2024

US$775.7 Million

Market Cap History

Everest Medicines Ltd market capitalization over time

Evolution of Everest Medicines Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Everest Medicines Ltd

Detailed Description

Everest Medicines Limited, a clinical-stage biopharmaceutical company, focuses on licensing, developing, and commercializing therapies for addressing critical unmet medical needs in Greater China and other Asia Pacific markets. It has a portfolio of eight clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal disease, and infectious diseases. Everest Medicines Limited was founded in 2017 and is headquartered in Shanghai, China.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Everest Medicines Ltd has the following listings and related stock indices.


Stock: HKEX: 1952 wb_incandescent

Stock: FSX: 6HN wb_incandescent

Details

Headquarters:

Plaza 66

Tower 1, Units 6601-6606 1266 West Nanjing Road

Shanghai, 200040

China